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INTRODUCTION
Dioxins are a group of chemically related environmental con-
taminants, consisting of three major groups : polychlorinated
dibenzo-p -dioxins (PCDDs) ; furans (PCDFs) ; and dioxin- like
polychlorinated biphenyls (DL-PCBs). PCDDs/PCDFs are unin-
tentionally produced during the process of waste incineration,
bleaching of paper pulp, herbicide production, and metal refinery
etc. (1), but emissions into the environment have decreased in
developed countries in recent years. DL-PCBs were generated as
contaminants of PCBs, which were produced for various industrial
uses until the 1970’s. Humans are exposed to PCDDs/PCDFs/DL-
PCBs through diet, air and soil (1, 2).
Toxicities of dioxins include carcinogenicity and endocrine,
immune, reproductive, and neurobehavioral effects (1). As a dietary
intake safety standard, the tolerable daily intake (TDI) range of
dioxins has been set to 1-4 pg Toxic Equivalents (TEQ)/kg/day by
the World Health Organization (WHO) (3). TDI was determined
on the basis of the body burden at which the most sensitive adverse
health effects, such as reproductive, immune, and developmental
effects, were observed in offspring, and by applying an uncertainty
factor of 10 (3).
In a review published in 2005 (4), we summarized the blood
levels and dietary intake of dioxins in general populations. It was
considered that the means or medians of dietary intake of dioxins in
various countries were lower than the upper end of the TDI set by
the WHO (4 pg/TEQ/kg/day). The associations between back-
ground exposure to dioxins and potential health effects, such as
diabetes (DM), thyroid function, endometriosis, and neurodevel-
opment of infants, were also reviewed.
Over the last few decades, countermeasures have been taken
against emission of dioxins into the environment in various devel-
oped countries. Therefore, it is of interest to review the time-
related changes in dioxin exposure among general populations.
The association between exposure to dioxins and DM was firstly
reported for occupationally exposed U.S. Air Force veterans (4). In
recent years, the etiological role of dioxins in the development of
not only DM but also its underlying conditions, such as insulin
resistance, impaired insulin secretion and metabolic syndrome
(MetS) among general populations, has become a matter of con-
cern.
In this paper, the author reviewed recent reports on the dietary
intake and blood levels of PCDDs/PCDFs/DL-PCBs among gen-
eral populations to investigate the trends of dioxin exposure. In
addition, the author reviewed recent epidemiologic studies on the
association between blood levels of dioxins and DM and related or
frequently coexistent metabolic diseases (insulin resistance/im-
paired β -cell function, MetS, and gout/hyperuricemia).
MATERIALS AND METHODS
Published reports were searched using MEDLINE. The key-
words used were “dioxins”, “dietary intake, and “trend” for temporal
changes in dietary intake, and “dioxins”, “blood or serum” and
“trend” for changes in blood levels. For the association between
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exposure to dioxins and metabolic diseases, the combinations of
keywords used were “dioxins” and “diabetes”, “dioxins” and
“insulin resistance or β -cell function”, “dioxins” and “metabolic
syndrome”, and “dioxins” and “gout or hyperuricemia”.
Publication time was restricted from January 2000 to October
2017. Papers which dealt with only dietary intake of PCDDs/
PCDFs or DL-PCBs were excluded. In addition, studies on dietary
intake and blood levels of dioxins were limited to those of general
populations or populations without heavy exposure. Most studies
related to DM and insulin resistance controlled the potential con-
founding effects by sex, age, and body mass index or waist cir-
cumference, using restriction, stratified analysis, or multivariate
analysis. In addition, most studies on MetS and gout/hyperurice-
mia controlled sex, age and alcohol drinking, and studies on gout/
hyperuricemia controlled body mass index or obesity.
Meta-analysis was performed for the associations of blood levels
of dioxins with MetS and Gout/hyperuricemia by the random-
effects model, using programming language R.
DECREASING TRENDOF DIETARY INTAKE
Assessing dietary intake of dioxins is crucial to evaluate the total
exposure because respiratory and skin exposures constitute only a
minor proportion of overall exposure (2). After 2000, several re-
searchers reported the temporal trends of dioxin intake (Table 1). It
should be noted that not all studies used the same survey methods
(market basket method or duplicate portion analysis), Toxic
Equivalency Factors (TEFs) (WHO 1998 or 2005), methods of
calculation (pgTEQ/day or pgTEQ/kg/day), or body weights
(50 kg, 70 kg, or weight of each study subject). In addition, one
study measured only dioxin intake from fish and shellfish.
Sasamoto et al. (5) estimated dietary intake of PCDDs/PCDFs/
DL-PCBs in Tokyo, Japan from 1999 to 2004, using the market
basket method. The mean daily intake of total TEQ ranged from
1.25 to 2.18 pg/kg/day (WHO-TEF 1998). A decreasing trend was
observed during the first three years. In Sweden, Darnerud et al.
(6) estimated dietary intake of dioxins using market basket data in
1999. Intake of total dioxins was 96 pgTEQ/day (WHO-TEQ 1998),
which was much lower than that reported in 1990 (255-300 pgTEQ/
day). Arisawa et al. (7) reported dietary intake of dioxins, estimated
using duplicate portion analysis of consecutive 3-day food samples,
among 374 Japanese adults. The mean (2002-2006) was 1.06
pgTEQ/kg/day (WHO-TEQ 1998). In multiple regression analy-
sis, a later survey year was significantly associated with lower die-
tary intake. When the period of the survey was extended to 2010,
the overall mean was 0.82 pgTEQ/kg/day (625 subjects, WHO-
TEQ 2005) (8). In a newly designed survey performed between
2011 and 2016, the estimated mean intake of 90 subjects was 0.49
pgTEQ/kg/day (8). Perelló et al. (9) examined the changes in the
dietary intake of dioxins in a Spanish population using the market
basket method. The estimated daily intake was 3.51 pgTEQ/kg/
day in 2000 and 0.60 pgTEQ/kg/day in 2010 (WHO-TEQ 2005).
Intake of dioxins from fish and seafood, dairy products, and meat
and meat products decreased by 83%, 92%, and 90%, respectively. In
Italy, the daily intake of dioxins estimated in the survey in 2014 was
0.27-0.63 pgTEQ/kg/day (duplicate diet study, WHO-TEQ 2005)
(10). This was considered to be lower than that estimated from
1994-1996 (2.28 pgTEQ/kg/day, WHO-TEQ 1998, market basket
method) (11), although different survey methods and TEFs were
used. In China, Zhang et al. (12) estimated the mean daily intake of
PCDDs/PCDFs/DL-PCBs among the general population, using
the market basket method. The mean intake was 0.59 pgTEQ/kg/
day (WHO-TEQ 2005) in 2011, which was approximately 14.8%
lower than that in 2007 (0.68 pgTEQ/kg/day). Perelló et al. (13)
estimated daily intake of PCDDs/PCDFs/DL-PCBs from fish and
seafood in a Spanish population using the market basket method.
The intake of PCDDs/PCDFs/DL-PCBs was 23.1 pgTEQ/day in
2012, which was much lower than that in 2000 (111.6 pgTEQ/kg/
day). When the intake was calculated per kg body weight, daily
intake did not exceed 1.0 pgTEQ/kg/day in various sex- and age-
categories. The decrease in PCDDs/PCDFs TEQ (-86%) was
somewhat larger than that in DL-PCBs TEQ (-77%).
When comparing the dietary intake with TDI, it is important to
assess not only the mean, but also the distribution, of the intake.
Mato et al. (2) estimated the distribution of the daily dioxin intake
using the Monte Carlo simulation method. The 95 percentile of the
daily intake in Japan was 2.91 pgTEQ/kg/day (WHO-TEQ 1998),
which was lower than the upper end of the TDI set by the WHO
(4.0 pgTEQ/kg/day) (3). Arisawa et al. (7) considered the distribu-
tion of the long-term intake of dioxins (WHO-TEQ 1998) in Japan
by applying random-effects one-way analysis of variance to the
repeatedly measured dietary intake of the same people, and ex-
cluding day-to-day within person variance. By assuming normal
distribution for log (dietary intake), the proportions of subjects
whose long-term dietary intake exceeded TDI set by the WHO
(4 pgTEQ/kg/day) and European Union (2 pgTEQ/kg/day) were
estimated at 0.06% and 2.9%, respectively (7). If the WHO-TEQ
2005 was used, the proportion of the population exceeding the TDI
may have been lower, mainly because of the lower TEFs of DL-
PCBs, as discussed later.
In summary, it is considered that the mean dietary intake of
dioxins has been decreasing in general populations of several coun-
tries in Europe and Asia. The most recently reported means are
equal to or less than 1.0 pgTEQ/kg/day. This decrease may be
mainly because of the reduced emission of dioxins into the environ-
ment due to strict regulations in the treatment and disposal of
waste. Although data are still limited, only a small percentage of the
general populations in Japan may ingest dioxins exceeding the
TDI. Some studies reported that the extent of the decrease was
larger for dietary intake of PCDDs/PCDFs than DL-PCBs. One
explanation may be that improvements in the process of waste
incineration that occurred in developed countries were effective to
reduce emissions of PCDDs/PCDFs, rather than DL-PCBs, into
the environment.
DECREASING TREND OF DIOXIN CONCENTRA-
TIONS IN BLOOD AND SERUM
After 2000, several studies examined the trends of dioxin con-
centrations in human blood and serum (Table 2). It should be
noted that different TEFs (North Atlantic Treaty Organization/
Committees on the Challenges of Modern Society [NATO/CCMS],
WHO 1998 and 2005) were used in these studies, and some studies
measured only PCDDs/PCDFs. When the WHO 2005 TEFs are
applied, blood levels of dioxins become approximately 26% lower
than when WHO 1998 TEF was used (14). In addition, in some
studies, study subjects consisted of not only general populations,
but also people living in the vicinity of a waste incinerator or a
chemical plant, or workers employed at a municipal waste incinera-
tor. However, exposure to dioxins from routes other than diet
(respiratory and skin exposure) may have been small, as sug-
gested by the blood dioxin levels. Unlike dietary intake, no safety
standards or reference range of serum or blood levels have been
set.
Wittsiepe et al. (15) reported a decreasing trend in PCDDs/
PCDFs levels in blood among a German population between 1991
and 1996. The mean PCDDs/PCDFs TEQ (NATO/CCMS) de-
creased from 42.67 pg/g lipid in 1991 to 20.74 pg/g lipid in 1996 (P=
0.01). Ferriby et al. (16) compared the mean serum levels of
PCDDs/PCDFs between the participants of the National Human
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Adipose Tissue Survey (1980-1981, 57 subjects) and the National
Health and Nutrition Examination Survey (NHANES) (2001-2002,
408 subjects) in the U.S. The means of the two surveys were 55 and
12.9 pgTEQ/g lipid, respectively. Uemura et al. (17) reported
blood levels of dioxins in 1,374 Japanese adults who were exam-
ined in 2002-2006. The blood levels of PCDDs/PCDFs, DL-PCBs
and total dioxins differed significantly according the survey year
(P0.001), with mean values being lowest in 2006. When the pe-
riod of the survey was extended to 2011 and WHO-TEF 2005 was
used (2,264 subjects), the overall mean was 19 pgTEQ/g lipid
(8). In a newly designed survey performed during 2011 and 2016,
the overall mean of 490 subjects was 11 pgTEQ/g lipid (8). Humblet
et al. (18) examined the temporal trend of dioxins in sera from 8
Russian women living in the vicinity of a chemical plant. The mean
total TEQ was 36 pg/g lipid in 2000, which decreased to 25 pg/g
lipid in 2009 (P = 0.007). In Korea, Park et al. (19) examined the
temporal trend of serum levels of dioxins from 2001 to 2011 among
954 subjects (workers at a municipal waste incinerator and people
living around or away from a waste incinerator). The overall mean
was 9.3 pgTEQ/g lipid for PCDDs/PCDFs and 5.4 pgTEQ/g lipid
for DL-PCBs. They reported that there was no clear decreasing
trend in the serum levels of PCDDs/PCDFs or DL-PCBs, although
formal statistical testing was not performed.
In summary, dioxin concentrations in blood and serum have
been decreasing in several countries in Europe and Asia, and U.S.A.
This decreasing trend may be mainly because of the decreased
dietary intake of dioxins.
POTENTIAL HEALTH EFFECTS ASSOCIATED WITH
ENVIRONMENTAL EXPOSURE TO PCDDs/PCDFs/
DL-PCBs
Diabetes
In 2006, Lee et al. (20) reported significant positive trends for the
associations of serum levels of six persistent organic pollutants
(POPs), including 1,2,3,4,6,7,8 -HpCDD, with the prevalence of
DM among participants of the 1999-2002 NHANES in the U.S.
(Table 3). Everett et al. (21) also examined the associations of
serum levels of 1,2,3,6,7,8 -HxCDD, PCB126 and p,p’-DDT with
DM in the 1999-2002 NHANES. The results showed that PCB126,
but not 1,2,3,6,7,8 -HxCDD, was significantly associated with the
prevalence of DM. Even when the subjects with poor liver or kidney
function were excluded, the results were unchanged. Jorgensen
Table 1. Trends of mean dietary intake of dioxins in various countries
Country Method No. of subjects Mean (pgTEQ/day) Mean (pgTEQ/kg/day) Year of survey TEF Reference Remarks
Japan Market basket 109.2 2.18 1999 WHO -TEF 1998 Sasamoto T, et al. (2006) [5] 50kg b.w.
93.3 1.87 2000
62.4 1.25 2001
80.1 1.60 2002
80.0 1.60 2003
77.5 1.55 2004
Sweden Market basket 255 - 300 1990 WHO -TEF 1998 Wicklund Glynn A, et al. (1996)
(123 foods) 96 1999 Darnerud PO, et al. (2006) [6]
Japan Duplicate portion
analysis
75 1.27 2002 WHO -TEF 1998 Arisawa K, et al. (2008) [7] b.w. of each subject
74 1.32 2003 P0.0001 by
Kruskal -Wallis test
75 1.02 2004
75 1.01 2005
75 0.65 2006
374 60.36 1.06 2002 - 2006
Spain Market basket 245.5 3.51 2000 WHO -TEF 2005 Perelló G, et al. (2012) [9] 70kg b.w.
78.1 1.12 2006
41.7 0.60 2010
Italy Market basket 2.28 1994 - 1996 WHO -TEF 1998 Fattore E, et al. (2006) [11]
Duplicate diet study 0.27 - 0.63 2014 WHO -TEF 2005 De Filippis SP, et al. (2014) [10]
China Market basket 0.68 2007 WHO -TEF 2005 Zhang L, et al. (2015) [12]
0.59 2011
Spain Market basket 111.6 2000 WHO -TEF 2005 Llobet JM, et al. (2003) fish and shellfish only
Spain Market basket 23.1 2012 Perelló G, et al. (2015) [13] fish and shellfish only
Japan Duplicate portion 625 0.82 2002 - 2010 WHO -TEF 2005 Japanese Ministry of
the Environment (2017) [8]
b.w. of each subject
analysis 90 0.49 2011 - 2016 WHO -TEF 2005 Japanese Ministry of
the Environment (2017) [8]
b.w. of each subject
P0.001 by t - test
TEQ : Toxic Equivalents, TEF : Toxicity equivalency factors.
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et al. (22) examined the association between the sum of ranks of
three DL-PCBs (115, 118 and 156) with DM and glucose metabo-
lism in 692 Greenland Inuit, who were highly exposed to POPs.
Sum of ranks of DL-PCBs were not significantly associated with
DM or impaired glucose tolerance (IGT). Gasull et al. (23) reported
that serum levels of PCB118 and three non-DL-PCBs were associ-
ated with an increased odds ratio (OR) of DM and pre-DM (125
mg/dl= plasma glucose levels= 110 mg/dl) in 886 subjects in
Catalonia, Spain. In the Adult Inuit Health Study (2,595 subjects)
(24), PCB 105 and 118, but not the sum of three DL-PCBs, were
significantly associated with self -reported diabetes. In these five
studies, concentrations of only 1-3 dioxin isomers were examined
as exposure variables, and a TEF-based approach was not used.
Uemura et al. (25) examined the relationships of 7 PCDDs, 9
PCDFs, and 12 DL-PCBs isomers in blood with the prevalence of
DM in 1,374 Japanese adults using a TEQ-based approach. PCDDs/
PCDFs TEQ, DL-PCBs TEQ, and total TEQ were all significantly
associated with the prevalence of DM. The association was strongest
for DL-PCBs, with an OR of 6.82 (95% confidence interval [CI] 2.59-
20.1, quartile [Q]4 vs. Q1+Q2). In a study by Everett et al. (26), total
TEQ, as well as individual dioxin isomers such as 1,2,3,6,7,8 -
HxCDD, OCDD, 2,3,4,7,8 -PeCDF, PCB169, 118, and 156, were
significantly associated with increased OR of DM, among partici-
pants of the 1999-2004 NHANES. Aminov et al. (27) reported that
the linear trend for the association between DL-PCBs TEQ (sum
of 6 isomers) and prevalent diabetes was significant (P = 0.010)
among 601 native Americans, after adjustment for the concentra-
tions of three organochlorine (OC) pesticides.
The results from prospective observations are different. Two
nested case-control studies examined the association between
serum levels of DL-PCBs with type 2 DM in general populations,
but neither study produced significant results (28, 29). Three
cohort studies have been reported regarding the association be-
tween high exposure to dioxins and DM. In the Yucheng cohort,
the presence of chloracne, a sign of acute heavy exposure, was sig-
nificantly associated with an increased risk of DM in women
(OR = 5.5, 95% CI 2.3-13.4), but not in men (OR = 1.7, 95% CI 0.7-
4.6) (30). In Great Lakes sport fish eaters in the U.S., there was no
significant trend for the multivariate -adjusted association between
serum levels of PCB118 and incidence rate of DM (P = 0.54) (31). In
980 women enrolled in the Seveso Womens’ Health Study, serum
levels of TCDD were not associated with development of DM
(hazard ratio [HR] = 0.66, 95% CI 0.24-1.85,135 ppt/ vs.20 ppt)
(32).
In summary, several cross-sectional studies on general popula-
tions showed significant associations between serum/blood levels
of PCDDs/PCDFs/DL-PCBs and DM. One problem that should
be considered when evaluating the effect of dioxin exposure on
DM is whether or not the TEQ-based approach is appropriate. If
the mechanisms mediated by the aryl hydrocarbon receptor
(Ah-R)play some roles in the development of DM, as suggested
by an experimental study using Ah-R null mice (33), an analysis
using the TEQ-based approach (25, 26) may be justified. However,
the fact that not only DL-PCBs, but also non-DL-PCBs, often show
significant relationships with DM (28, 34) suggests that involve-
ment of mechanisms not mediated by Ah-R should also be consid-
ered in the pathogenesis of DM. Another problem when interpret-
ing the previous studies on DM is the inconsistency between cross-
sectional studies on general populations (20, 21, 25, 26) and pro-
spective studies on populations with heavy exposure (31, 32) or
general populations (28, 29). Heterogeneities in the results with
respect to study design and exposure levels have been pointed
Table 2. Trends of mean or median concentrations of dioxins in blood and serum (pgTEQ/g lipid) in general populations of various countries
Country Population No. of subjects Samples Mean Median Year of survey TEF Reference Remarks
Germany General population 95 blood 42.67 (PCDD/Fs) 1991 NATO/CCMS -TEF Wittsiepe J, et al. (2000) [15] P = 0.01 (1991 vs. 1996)
157 38.12 (PCDD/Fs) 1992
17 29.05 (PCDD/Fs) 1993
74 29.13 (PCDD/Fs) 1994
69 24.06 (PCDD/Fs) 1995
95 20.74 (PCDD/Fs) 1996
U.S.A. NHATS 1980 - 1981 57 serum 55 (PCDDs/Fs) 1980 - 1981 WHO -TEF 1998 Ferriby LL, et al. (2007) [16]
NHANES 2001 - 2002 408 12.9 (PCDDs/Fs) 2001 - 2002
Japan General population 259 blood 26.7 2002 WHO -TEF 1998 Uemura H, et al. (2008) [17] P0.001 by KrusKal -Wallis test
272 23.6 2003
264 23.7 2004
288 25.6 2005
291 21.0 2006
Russia Women living in the
vicinity of a chemical
plant
8 serum 36 2000 WHO -TEF 2005 Humblet O, et al. (2011) [18] Same subjects
25 2009 P = 0.007 by Paired t - test
Korea Residents, workers 954 serum 9.29 (PCDD/Fs) 2001 - 2011 WHO -TEF 2005 Park H, et al. (2014) [19] no decreasing trend
8.15 (PCDD/Fs)
Residents, workers 539 5.39 (DL - PCBs) no decreasing trend
4.51 (DL - PCBs)
Japan General population 2264 blood 19 2002 - 2010 WHO -TEF 2005 Japanese Ministry of the
Environment (2017) [8]
P0.001 by t - test
490 11 2011 - 2016 WHO -TEF 2005 Japanese Ministry of the
Environment (2017) [8]
TEQ : Toxic Equivalents, TEF : Toxicity equivalency factors, NATO/CCMS : North Atlantic Treaty Organization/Committees on the Challenges of
Modern Society, NHATS : National Human Adipose Tissue Survey, NHANES : National Health and Nutrition Examination Survey.
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Table 3. Associations of exposure to dioxins with diabetes, insulin resistance and insulin secretion
Country Population No. of subjects Type of study Outcome Exposure (pg/g lipid) or pgTEQ/g lipid) Association Reference Remarks
U.S.A. NHANES 1999 - 2002 2016 Cross - sectional Diabetes 1,2,3,4,6,7,8HpCDD OR = 2.7* (highest/lowest), P for trend = 0.007 Lee DH, et al. (2006) [20]
OCDD OR = 2.1 (highest/lowest, N.S.), P for trend = 0.094
U.S.A. NHANES 1999 - 2002 1830 Cross - sectional Diabetes 1,2,3,6,7,8HxCDD OR = 1.99 (highest/lowset, N.S.) Everett CJ, et al. (2007) [21]
PCB126 OR = 3.68* (highest/lowest)
Denmark Greenland Inuit 692 Cross - sectional Diabetes DL - PCBs (sum of ranks of 3 isomers) OR = 1.2 (highest/lowest, N.S.), P for trend = 0.37 Jorgensen ME, et al. (2008) [22]
IGT DL - PCBs (sum of ranks of 3 isomers) OR = 0.7 (highest/lowest, N.S.), P for trend = 0.82
Taiwan Yucheng 748 Cohort Diabetes (presence of chloracne) OR = 1.7 (chloracne +/ -, N.S., Men) Wang SL, et al. (2008) [30]
OR = 5.5* (chloracne +/ -, Women)
U.S.A. Great lakes sport
fish consumers
471 Cohort Diabetes PCB118 HR = 1.3 (highest/lowest, N.S.), P for trend = 0.54 Turyk M, et al. (2009) [31]
Japan General population 1374 Cross - sectional Diabetes PCDDs + PCDFs TEQ (1998) OR = 2.21* (= 18 vs. 12) Uemura H, et al. (2009) [25]
DL - PCBs TEQ (1998) OR = 6.82* (= 13 vs. 7.6)
Total TEQ (1998) OR = 3.81* (= 31 vs.20)
Sweden General population 725 Nested case - control Diabetes PCB105 OR = 8.0 (highest/lowest, N.S.), P for trend = 0.30 Lee DH, et al. (2011) [28]
PCB118 OR = 3.6 (highest/lowest, N.S.), P for trend = 0.19
PCB156 OR = 2.6 (highest/lowest, N.S.), P for trend = 0.14
PCB157 OR = 2.9 (highest/lowest, N.S.), P for trend = 0.07
PCB189 OR = 2.8 (highest/lowest, N.S.), P for trend = 0.12
U.S.A. NHANES 1999 - 2004 2611 Cross - sectional Diabetes 1,2,3,6,7,8HxCDD OR = 2.25* (highest/lowest) Everett CJ, et al. (2012) [26]
OCDD OR = 1.82* (highest/lowest)
2,3,4,7,8PeCDF OR = 2.39* (highest/lowest)
PCB169 OR = 2.56* (highest/lowest)
PCB118 OR = 3.53* (highest/lowest)
PCB156 OR = 2.47* (highest/lowest)
Total TEQ (2005) OR = 3.08* (= 81.58 vs. 13.82)
Spain General population 886 Cross - sectional Diabetes PCB118 OR = 2.1* (highest/lowest), P for trend = 0.048 Gasull M, et al. (2012) [23]
Pre - diabetes PCB118 OR = 2.1* (highest/lowest), P for trend = 0.007
Italy Seveso women 980 Cohort Diabetes TCDD HR = 0.66 (135 vs.= 20, N.S.), P for trend = 0.09 Warner M, et al. (2013) [32]
U.S.A. Nurses’ Health Study 1095 Nested case - control Diabetes PCB118 OR = 1.41 (highest/lowest, N.S.), P for trend = 0.43 Wu H, et al. (2013) [29]
U.S.A. Native Americans 601 Cross - sectional Diabetes DL - PCB TEQ (2005, sum of 6 isomers) OR = 1.82 (highest/lowest, N.S.), P for trend = 0.010 Aminov Z, et al. (2016) [27] Adjusted for pesticides
(10 - 5 ng/ g wet weight)
Canada Arctic Inuit 2595 Cross - sectional Diabetes PCB105 P0.05 (highest/lowest) Singh K., Chan HM (2017) [24]
PCB118 P0.05 (highest/lowest)
DL - PCBs (sum of 3 isomers) N.S. (highest/lowest)
Denmark Greenland Inuit 692 Cross - sectional HOMA - IR DL - PCBs (sum of ranks of 3 isomers) N.S． Jorgensen ME, et al. (2008) [22]
HOMA - β P0.05 (- 8.5%/quartile)
Taiwan Contaminated area 1449 Cross - sectional HOMA - IR PCDDs/PCDFs TEQ (1998) P0.001 Chang JW, et al. (2011) [36] Mean = 33.2 pgTEQ/g lipid
HOMA - β PCDDs/PCDFs TEQ (1998) P = 0.030 (positive correlation)
Finland Fishermen 123 (Men) Cross - sectional HOMA - IR Total TEQ 1.74/1.30 (highest/lowest, Men), P for trend = 0.09 Turunen AW, et al. (2013) [38] Mean = 98 pgTEQ/g lipid (Men)
132 (Women) 1.28/1.43 (highest/lowest, Women), P for trend = 0.49 Mean = 54 pgTEQ/g lipid (Women)
HOMA - β Total TEQ 63.2%/50.2% (highest/lowest, Men), P for trend = 0.10 Dietary habit was adjusted
63.2%/77.1% (highest/lowest, Women), P for trend = 0.17 BMI was not adjusted
Korea General population 83 (T2DM) Case - control Diabetes Ah - R ligand activity (TCDD equivalent) OR = 2.26 (log2(Ah-R ligand), P = 0.002) Roh E, et al. (2015) [39]
130 (IGT)
83 (Control) Cross - sectional HOMA - IR Ah - R ligand activity (TCDD equivalent) Pearson r = 0.289(P0.001) BMI was not adjusted for
HOMA - IIR and HOMA - βHOMA - β Ah - R ligand activity (TCDD equivalent) Pearson r = 0.079 (P = 0.334)
Taiwan Contaminated area 1466 (Men) Cross - sectional HOMA - IR PCDDs/PCDFs TEQ (1998) OR = 2.46* (= 19.35 vs.19.35, Men) Chang JW, et al. (2016) [37] Mean = 25.4 pgTEQ/g lipid
1410 (Women) PCDDs/PCDFs TEQ (1998) OR = 1.11 (= 23.25 vs.23.25, N.S., Women) Mean = 34.8 pgTEQ/g lipid
TEQ : Toxic Equivalents, NHANES : National Health and Nutrition Examination Survey, OR : odds ratio, IGT : impaired glucose tolerance, HR : hazard ratio, HOMA- IR : Homeostasis Model Assessment -
Insulin Resistance, HOMA-β : Homeostasis Model Assessment -β, T2DM : type 2 diabetes, Ah -R : aryl hydrocarbon receptor.
* P0.05, N.S. : not significant.
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out in a meta-analysis on dioxin exposure and DM (35).
Insulin resistance and β cell function
Several cross-sectional studies have examined the association
between environmental exposure to dioxins and insulin resistance/β
cell function (Table 3). In epidemiologic studies, Homeostasis
Model Assessment (HOMA)-Insulin Resistance (IR) and HOMA-β
are defined using the following equations, and are often used as an
index of insulin resistance and β cell function, respectively.
HOMA-IR = insulin (μU/ml) × fasting blood glucose (mg/
dl)/405
HOMA-β (%) = (360 × insulin [μU/ml])/(glucose [mg/dl] -
63)
Jorgensen et al. (22) examined the association between serum
levels of DL-PCBs and glucose homeostasis among 692 Greenland
Inuit. There was a significant inverse association with HOMA-β
(-8.5% /quartile), but no association with HOMA-IR. Chang et al.
(36) examined the correlations of serum levels of PCDDs/PCDFs
TEQ with HOMA-IR among 1,449 subjects living near a deserted
pentachlorophenol factory in Taiwan from 2005 to 2007. The mean
PCDDs/PCDFs TEQ was 33.2 pg/g lipid (WHO 1998 TEF), sug-
gesting somewhat high exposure. In multiple regression analysis,
PCDDs/PCDFs TEQ in serum was significantly associated with
HOMA-IR (P0.001). HOMA-IR increased as serum levels of
PCDDs/PCDFs and blood levels of mercury increased. The same
research team performed a cross-sectional study on 1,466 men and
1,410 women living in the same study area from 2005 to 2010 (37).
High serum levels of PCDDs/PCDFs TEQ were significantly
associated with insulin resistance, defined as HOMA-IR75
percentile, in men (OR = 2.46, 95% CI 1.63-3.70), but not in women
(OR = 1.11, 95% CI 0.58-2.12), when abdominal obesity was absent.
Turunen et al. (38) examined the association between total TEQ in
blood and glucose homeostasis among fishermen (123 males and
132 females) in Finland. The mean blood level of total dioxins
was 98 pgTEQ/g lipid for men and 54 pgTEQ/g lipid for women,
indicating high exposure. The P for trend for the association of total
TEQ with HOMA-IR was 0.09 for men and 0.49 for women. The P
for trend of total TEQ with HOMA-β was 0.10 for men and 0.17 for
women. Roh et al. (39) performed a case-control study on the
association between blood levels of dioxins (estimated by Ah-R
ligand activity) and DM (83 patients with DM, 130 patients with
IGT, and 83 controls). When the subjects with IGT and controls
were combined, there was a significant positive correlation be-
tween log2(Ah-R ligand activity) and HOMA-IR (r= 0.29, P0.001),
but not between log2(Ah-R ligand activity) and HOMA-β (r = 0.08,
P=0.33).
In summary, significant positive correlations of serum levels of
dioxins with insulin resistance and a significant inverse correlation
with β -cell function have been reported in some studies, but the
results are inconsistent. The results may not depend on the
characteristics of each population (general or highly exposed) or
chemical substances (PCDDs/PCDFs, DL-PCBs), or use or no
use of a TEQ-based approach.
Metabolic syndrome (MetS)
Metabolic syndrome is characterized by the clustering of vis-
ceral obesity, high blood pressure, high serum triglyceride levels,
low serum HDL-cholesterol levels, and high fasting blood glucose,
often accompanied by a pro- inflammatory state and pro-throm-
botic state (40). People with MetS are at an increased risk for
developing type 2 DM and cardiovascular diseases (41-43). Life-
style factors, such as excessive energy intake, a western dietary
pattern, and low physical activity levels, are known as risk factors
for the development of MetS (40, 44). Recently, environmental
exposure to POPs, including dioxins, has attracted attention as a
potential etiological factor for MetS.
Lee et al. (45) explored the association between serum levels of
various POPs and the prevalence of MetS in 721 U.S. adults who
participated in the 1999-2002 NHANES survey (Table 4). There
were significant positive dose-response relationships betweenDL-
PCBs (sum of ranks of 4 isomers, PCB74, 118, 126, 169), 1,2,3,4,7,8 -
HxCDF and OC pesticides (sum of ranks of 4 substances), and
MetS. The strongest association was found for OC pesticides. On
the other hand, there was no association between serum levels of
PCDDs (sum of ranks of 3 isomers) or PCDFs (sum of ranks of 3
isomers) and MetS. Uemura et al. (46) examined the associa-
tions of 29 PCDDs/PCDFs/DL-PCBs isomers in blood with the
prevalence of MetS in 1,374 Japanese subjects. Significant positive
trends were observed for TEQs of PCDDs and DL-PCBs, total
TEQ, and concentrations of 4 PCDDs, 1 PCDF, and 6 DL-PCBs.
The results were essentially unchanged regardless of whether or
not the subjects with diabetes were excluded from the analysis. In
Taiwan, Chang et al. (47) examined the association between serum
levels of 17 PCDDs/PCDFs isomers and the prevalence of MetS in
1,490 subjects living near a highly contaminated area. The mean
TCDDs/PCDFs TEQ (WHO 1998) in serum (31.2 pgTEQ/g lipid)
was higher than that of general populations in Japan (Median = 20
pgTEQ/g lipid [WHO TEF 1998]) (17) and Korea (Mean = 9.12
pgTEQ/g lipid [WHO TEF 2005]) (19), suggesting the presence of
excessive exposure. The P for trend was significant for TEQ of
PCDDs/PCDFs and concentrations of 14 PCDDs/PCDFs iso-
mers. In a case-control study conducted in Korea (23 patients with
DM, 23 patients with impaired fasting glycaemia, and 50 controls),
serum levels of Ah-R ligand activity were significantly associated
with the presence of DM andMetS (48). In Canada, Gauthier et al.
(49) performed a case-control study on obesity -associated meta-
bolic abnormality and serum levels of various POPs. Cases con-
sisted of obese people with insulin resistance and metabolic abnor-
malities, while controls were those who were obese, but had no
insulin resistance. The sum of concentrations of 5 DL-PCBs and9
non-DL-PCBs (=median) was significantly associated with case/
control status, with an OR of 4.7 (95% CI 1.8-12.5). However, ORs
were not separately estimated for DL-PCBs and non-DL-PCBs.
Warner et al. prospectively examined the association between
exposure to TCDD and MetS in Seveso women (median serum
TCDD = 55.9 ppt) (32). Serum levels of log10 (TCDD) were signifi-
cantly associated with the presence of MetS among those who were
equal to or less than 12 years of age at the timeof exposure (OR =
2.03, 95% CI 1.25-3.30), but not among the remainder of the co-
hort (OR = 0.96, 95% CI 0.68-1.35). In a cohort study of the Swedish
general population, PCB 126 and 118, butnot OCDD in plasma (wet-
weight based concentration), were associated with significantly in-
creased OR of MetS (50).
When the random effects model was applied to three large scale
cross-sectional studies (45-47), summary ORs for the highest cate-
gory relative to the lowest category of PCDDs, PCDFs, and DL-
PCBs were estimated at 1.9 (95% CI 1.2-3.0, P for heterogeneity =
0.16, Fig. 1a), 1.9 (95% CI 1.3-3.0, P for heterogeneity = 0.25, Fig. 1b),
and 3.8 (95% CI 1.1-13, P for heterogeneity = 0.04, Fig. 1c), respec-
tively. All summary ORs were significantly higher than 1.0.
These results suggest that serum/blood levels of PCDDs/PCDFs
and DL-PCBs were significantly associated with MetS, despite
some differences in the study design (use of concentrations, sum of
ranks, TEQs, or Ah-R ligand activity) and inconsistencies in chemical
substances that showed significant associations with MetS. Possi-
ble biological mechanisms include obesogenic effects of dioxins
observed in experimental animals (51) and humans (52), and Ah-R
mediated effects on expression of genes involved in inflammatory
pathways, such as interleukin 1β (IL1B), interleukin 8 (IL8), inter-
leukin receptor antagonist (IL1ra), and prostaglandin-endoperoxide
synthase 2 (PTGS2) (53). Further experimental and prospective
studies are needed to draw a firm conclusion.
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Gout and hyperuricemia
Nakamoto et al. (54) first reported that there were significant
positive trends between TEQs of PCDDs/PCDFs, DL-PCBs and
total TEQ in blood, and a history of gout in 1,051 Japanese men
(Table 4). Lee et al. (55) also examined the association of serum
levels of 3 PCDDs, 2 PCDFs and 8 DL-PCBs (sum of rank of each
isomer) with hyperuricemia among 1,118 U.S. adults (NHANES
2003-2004 sample). Significant positive trends were observed for
PCDDs and DL-PCBs. Chang et al. (56) reported a positive trend
between PCDDs/PCDFs TEQ and hyperuricemia in 715 U.S. men
who were residing near a pentachlorophenol factory (Geometric
mean PCDDs/PCDFs TEQ in serum = 12.4 pgTEQ/g lipid). When
the random effects model was applied to two studies that used
PCDDs/PCDFs TEQ as an exposure variable (54, 56), the summary
OR of Q4 relative to Q1 was estimated at 3.8 (95% CI 1.6-8.9, P for
heterogeneity = 0.24, figure not shown).
These consistent results suggest that exposure to dioxins is a
risk factor for gout/hyperuricemia. However, another possible ex-
planation is that risk factors for gout/hyperuricemia and high expo-
sure to dioxins overlap each other. Blood levels of dioxins (15-17)
and the prevalence of gout (57) generally increase with age. Purine-
rich foods, such as meat and seafood are risk factors for gout (57)
and major dietary sources of dioxins (5). Alcohol drinking, an es-
tablished risk factor for gout, was associated with high blood
levels of dioxins, independent of fish intake (58). In addition,
obesity is often accompanied by high blood levels of dioxins and
hyperuricemia. Age, body mass index and alcohol drinking, but not
intake of purine, were adjusted in three studies on gout/hyperu-
ricemia (54-56). Therefore, confounding by intake of purine should
be controlled in future epidemiologic studies.
CONCLUSION
In this paper, the author reviewed the recent studies on the
Table 4. Association between exposure to dioxins and metabolic syndrome and gout/hyperuricemia
Country Population No. of subjects Design Outcome Exposure (pg/g lipid or pgTEQ/g lipid) Association Reference Remarks
U.S.A. NHANES
(1999 - 2002)
721 Cross - sectional Metabolic syndrome 3 PCDDs (sum of ranks) OR = 1.3 (highest/lowest, N.S.), P for trend = 0.35 Lee DH, et al. (2007) [45]
4 PCDFs (sum of ranks) OR = 1.6 (highest/lowest, N.S.), P for trend = 0.11
1,2,3,4,7,8 - HxCDF OR = 2.0* (highest/lowest), P for trend0.01
4 DL - PCBs (sum of ranks) OR = 2.1* (highest/lowest), P for trend = 0.01
PCB 74, 118, 126 P for trend0.01
(4 organochlorine pesticides, sum of ranks) OR = 5.3* (highest/lowest), P for trend0.01
Japan General population 1374 Cross - sectional Metabolic syndrome PCDDs TEQ (1998) OR = 3.4* (= 11 vs.4.49), P for trend0.01 Uemura H, et al. (2009) [46] Subjects with diabetes were excluded
DL - PCBs TEQ (1998) OR = 7.3* (= 12.87 vs.4.28), P for trend0.01
Total TEQ (1998) OR = 5.1* (= 30 vs.12), P for trend0.01
11 isomers P for trend0.05
Taiwan Polluted area 1490 Cross - sectional Metabolic syndrome PCDDs/PCDFs TEQ (1998) OR = 2.3* (highest/lowest), P for trend0.001 Chang JW, et al. (2010) [47] Mean = 31.2 pgTEQ/g lipid
PCDDs OR = 1.7* (highest/lowest), P for trend0.001
PCDFs OR = 1.7* (highest/lowest), P for trend0.001
14 isomers P for trend0.01
Korea General population Diabetes 23 Case - control Metabolic syndrome Ah - R ligand activity P0.05 Park WH, et al. (2013) [48]
IFG 23 DM P0.05
Control 50
Italy Seveso women 806 Cohort Metabolic syndrome TCDD OR = 2.03* (log10(TCDD)) Warner M, et al. (2013) [32] Median of TCDD = 55.9 ppt
(age= 12 y at explosion)
OR = 0.96 (log10(TCDD), N.S.)
(age12 y at explosion)
P interaction (age) = 0.01
Canada General population MAO 40 Case - control Metabolicaly
abnormal obese
5 DL - PCBs + 9 nonDL - PCBs (pg/mL)
(Trans nonachlor , pg/mL)
OR = 4.7* (= Median/Median) Gauthier MS, et al. (2014) [49] Alcohol drinking was not adjusted
MHO 36 OR = 6.1* (= Median/Median)
Sweden General population 452 Cohort Metabolic syndrome PCB126 (pg/mL) OR = 1.73* (highest/lowest) Lind L, et al. (2017) [50]
PCB118 (pg/mL) OR = 1.36* (highest/lowest)
OCDD (pg/mL) N.S.
Japan General population 1051 men Cross - sectional Gout PCDDs/PCDFs TEQ (2005) OR = 8.7* (= 15.05 vs.6.075), P for trend = 0.02 Nakamoto M, et al. (2013) [54]
DL - PCBsTEQ (2005) OR = 3.3 (= 10 vs.3.2, N.S.), P for trend = 0.04
Total TEQ (2005) OR = 6.2* (= 25 vs.9.7), P for trend = 0.007
U.S.A． NHANES
(2003 - 2004)
1118 Cross - sectional Hyperuricemia 3 PCDDs (sum of ranks) OR = 2.5* (highest/lowest), P for trend = 0.01 Lee, YM et al. (2013) [55]
2 PCDFs (sum of ranks) OR = 1.9* (highest/lowest), P for trend = 0.11
8 DL - PCBs (sum of ranks) OR = 2.4* (highest/lowest), P for trend = 0.04
U.S.A． Polluted area 715 men Cross - sectional Hyperuricemia PCDDs/PCDFs TEQ (2005) OR = 3.0* (= 17.7 vs.7.4) Chang, JW, et al. (2013) [56] Geometric mean = 12.4 pgTEQ/g lipid
TEQ : Toxic Equivalents, NHANES : National Health and Nutrition Examination Survey, IFG : Impaired fasting Glycaemia, OR : odds ratio, MAO : Metabolically abnormal obese, MHO : Metabolically
healthy obese.
* P0.05, N.S. : not significant.
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temporal changes in blood levels and dietary intake of dioxins
among general populations, and epidemiologic studies on the
associations of blood levels of dioxins with metabolic diseases. In
recent years, dietary intake and blood levels of dioxins has been
decreasing in general populations in various countries. Many cross-
sectional studies reported positive associations between blood levels
of PCDDs/PCDFs/DL-PCBs and diabetes in general populations.
However, the results from prospective studies on populations with
heavy exposure and general populations are inconsistent. Four
cross-sectional or case-control studies and two cohort studies
(Seveso Women’s Study and one study on a general population)
consistently reported a significant positive association between
blood levels of dioxins and metabolic syndrome. Meta-analysis
performed in this study showed significantly increased ORs of
metabolic syndrome associated with higher blood levels of PCDDs/
PCDFs/DL-PCBs. In addition, three cross-sectional studies re-
ported significant positive associations with gout/hyperuricemia.
Further prospective studies and experimental studies are neces-
sary to establish cause-effect relationships, and to clarify the bio-
logical mechanisms.
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Figure1.
Meta-analysis for the association between blood levels of PCDDs (1a), PCDFs (1b) and DL-PCBs (1c), and the prevalence of metabolic syndrome
using a random effects model. Summary ORs for the highest category relative to the lowest category of PCDDs, PCDFs, and DL-PCBs were
estimated at 1.9 (95% CI 1.2 -3.0, P for heterogeneity = 0.16), 1.9 (95% CI 1.3 -3.0, P for heterogeneity = 0.25), and 3.8 (95% CI 1.1 -13, P for
heterogeneity = 0.04), respectively. All ORs were significantly higher than 1.0.
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